Bisoprolol Fumarate And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-5849

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bisoprolol Fumarate And Hydrochlorothiazide (NDC 50090-5849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Biso Api Structure (Api Pic New1)

FDA Label Image

Hctz Api Structure (Api Pic New2)

FDA Label Image

Label Image (Lbl500905849)

FDA Label Image

Table 1 (Table 1 New)

Table 1 (Table 1 New)
This is a study report on the sitting systolic/diastolic pressure (BP) and heart rate (HR) in response to medication. The report presents two studies: Study 1 and Study 2. The decrease in mean after 3.4 weeks is presented in the table, along with the observed mean change from baseline minus placebo. The report also shows the drug effect on BP and HR in both studies.*
FDA Label Image

Table-3 (Table 3 New)

FDA Label Image

Table-2 (Table New 2)

Table-2 (Table New 2)
This appears to be a table with serum potassium data from a placebo-controlled study in the US. It includes mean change values for serum potassium levels between 2004 and 7011 and percentages for hypolalemia.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.